3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Near-Infrared Photobiomodulation of Living Cells, Tubulin, and Microtubules In Vitro

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We report the results of experimental investigations involving photobiomodulation (PBM) of living cells, tubulin, and microtubules in buffer solutions exposed to near-infrared (NIR) light emitted from an 810 nm LED with a power density of 25 mW/cm 2 pulsed at a frequency of 10 Hz. In the first group of experiments, we measured changes in the alternating current (AC) ionic conductivity in the 50–100 kHz range of HeLa and U251 cancer cell lines as living cells exposed to PBM for 60 min, and an increased resistance compared to the control cells was observed. In the second group of experiments, we investigated the stability and polymerization of microtubules under exposure to PBM. The protein buffer solution used was a mixture of Britton-Robinson buffer (BRB aka PEM) and microtubule cushion buffer. Exposure of Taxol-stabilized microtubules (~2 μM tubulin) to the LED for 120 min resulted in gradual disassembly of microtubules observed in fluorescence microscopy images. These results were compared to controls where microtubules remained stable. In the third group of experiments, we performed turbidity measurements throughout the tubulin polymerization process to quantify the rate and amount of polymerization for PBM-exposed tubulin vs. unexposed tubulin samples, using tubulin resuspended to final concentrations of ~ 22.7 μM and ~ 45.5 μM in the same buffer solution as before. Compared to the unexposed control samples, absorbance measurement results demonstrated a slower rate and reduced overall amount of polymerization in the less concentrated tubulin samples exposed to PBM for 30 min with the parameters mentioned above. Paradoxically, the opposite effect was observed in the 45.5 μM tubulin samples, demonstrating a remarkable increase in the polymerization rates and total polymer mass achieved after exposure to PBM. These results on the effects of PBM on living cells, tubulin, and microtubules are novel, further validating the modulating effects of PBM and contributing to designing more effective PBM parameters. Finally, potential consequences for the use of PBM in the context of neurodegenerative diseases are discussed.

          Related collections

          Most cited references78

          • Record: found
          • Abstract: found
          • Article: not found

          Electrostatics of nanosystems: application to microtubules and the ribosome.

          Evaluation of the electrostatic properties of biomolecules has become a standard practice in molecular biophysics. Foremost among the models used to elucidate the electrostatic potential is the Poisson-Boltzmann equation; however, existing methods for solving this equation have limited the scope of accurate electrostatic calculations to relatively small biomolecular systems. Here we present the application of numerical methods to enable the trivially parallel solution of the Poisson-Boltzmann equation for supramolecular structures that are orders of magnitude larger in size. As a demonstration of this methodology, electrostatic potentials have been calculated for large microtubule and ribosome structures. The results point to the likely role of electrostatics in a variety of activities of these structures.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.

            We have recently shown that low intensity, intermediate frequency, electric fields inhibit by an anti-microtubule mechanism of action, cancerous cell growth in vitro. Using implanted electrodes, these fields were also shown to inhibit the growth of dermal tumors in mice. The present study extends these findings to additional cell lines [human breast carcinoma; MDA-MB-231, and human non-small-cell lung carcinoma (H1299)] and to animal tumor models (intradermal B16F1 melanoma and intracranial F-98 glioma) using external insulated electrodes. These findings led to the initiation of a pilot clinical trial of the effects of TTFields in 10 patients with recurrent glioblastoma (GBM). Median time to disease progression in these patients was 26.1 weeks and median overall survival was 62.2 weeks. These time to disease progression and OS values are more than double the reported medians of historical control patients. No device-related serious adverse events were seen after >70 months of cumulative treatment in all of the patients. The only device-related side effect seen was a mild to moderate contact dermatitis beneath the field delivering electrodes. We conclude that TTFields are a safe and effective new treatment modality which effectively slows down tumor growth in vitro, in vivo and, as demonstrated here, in human cancer patients.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Disruption of cancer cell replication by alternating electric fields.

              Low-intensity, intermediate-frequency (100-300 kHz), alternating electric fields, delivered by means of insulated electrodes, were found to have a profound inhibitory effect on the growth rate of a variety of human and rodent tumor cell lines (Patricia C, U-118, U-87, H-1299, MDA231, PC3, B16F1, F-98, C-6, RG2, and CT-26) and malignant tumors in animals. This effect, shown to be nonthermal, selectively affects dividing cells while quiescent cells are left intact. These fields act in two modes: arrest of cell proliferation and destruction of cells while undergoing division. Both effects are demonstrated when such fields are applied for 24 h to cells undergoing mitosis that is oriented roughly along the field direction. The first mode of action is manifested by interference with the proper formation of the mitotic spindle, whereas the second results in rapid disintegration of the dividing cells. Both effects, which are frequency dependent, are consistent with the computed directional forces exerted by these specific fields on charges and dipoles within the dividing cells. In vivo treatment of tumors in C57BL/6 and BALB/c mice (B16F1 and CT-26 syngeneic tumor models, respectively), resulted in significant slowing of tumor growth and extensive destruction of tumor cells within 3-6 days. These findings demonstrate the potential applicability of the described electric fields as a novel therapeutic modality for malignant tumors.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Med Technol
                Front Med Technol
                Front. Med. Technol.
                Frontiers in Medical Technology
                Frontiers Media S.A.
                2673-3129
                04 May 2022
                2022
                : 4
                : 871196
                Affiliations
                [1] 1Department of Physics, University of Alberta , Edmonton, AB, Canada
                [2] 2Department of Mechanical and Aerospace Engineering, Politecnico di Torino , Turin, Italy
                [3] 3Scholes Lab, Department of Chemistry, Princeton University , Princeton, NJ, United States
                [4] 4Vielight Inc. , Toronto, ON, Canada
                [5] 5Department of Oncology, University of Alberta , Edmonton, AB, Canada
                Author notes

                Edited by: Sundeep Singh, University of Calgary, Canada

                Reviewed by: Farzad Salehpour, The University of Texas at Austin, United States; Felipe-Andres Piedra, Baylor College of Medicine, United States

                *Correspondence: Jack A. Tuszyński jackt@ 123456ualberta.ca

                This article was submitted to Original Research Article, a section of the journal Frontiers in Medical Technology

                †These authors have contributed equally to this work

                Article
                10.3389/fmedt.2022.871196
                9115106
                8e52e084-29c3-47a9-bd3a-0f5662d98d4c
                Copyright © 2022 Staelens, Di Gregorio, Kalra, Le, Hosseinkhah, Karimpoor, Lim and Tuszyński.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 07 February 2022
                : 14 March 2022
                Page count
                Figures: 12, Tables: 2, Equations: 2, References: 79, Pages: 20, Words: 12364
                Funding
                Funded by: Natural Sciences and Engineering Research Council of Canada, doi 10.13039/501100000038;
                Categories
                Medical Technology
                Original Research

                photobiomodulation,cells,tubulin,microtubules,therapeutic devices,medical technologies,neurodegenerative diseases

                Comments

                Comment on this article